| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7490c3301ce0fad5060c30b7e8085dee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf0b34c358de371edb2c137617580780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed4df23f2382ae14f85834149da745a7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2013-08-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59b62fe85266a7fc9e0bbbcbe4e8b70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e6e5a4ae13d34f4dfa2e5474c1c1fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a35ea33a6f5ecf963148eec247f415 |
| publicationDate |
2014-02-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014037637-A1 |
| titleOfInvention |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) |
| abstract |
The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGFβ superfamily protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016054155-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10138295-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170002445-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102550926-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10975140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10647758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015175639-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385119-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578341-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-037980-B1 |
| priorityDate |
2012-08-01^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |